Roy S, Loh H H
Department of Pharmacology, University of Minnesota, Minneapolis, 55455, USA.
Neurochem Res. 1996 Nov;21(11):1375-86. doi: 10.1007/BF02532379.
Both therapeutic and chronic uses of opioids compromise the optimal functioning of the immune system. Overwhelming evidence suggests that opioid use affects both innate immunity and adaptive immunity. Chronic administration of opioids decreases the proliferative capacity of macrophage progenitor cells and lymphocytes. Additionally, the differentiated function of immune cells is significantly affected by opioids. These effects are mediated by either a direct action of opioids on the target cells or by indirect centrally mediated pathways. Molecular biological and biochemical characterization suggest that immune cells differentially express classical opioid receptors. Interestingly, these studies also reveal the presence of a novel class of opioid receptors in immune cells. We believe that this low affinity morphine binding site mediates the antiproliferative effects of morphine.
阿片类药物的治疗性使用和长期使用都会损害免疫系统的最佳功能。大量证据表明,阿片类药物的使用会影响固有免疫和适应性免疫。长期服用阿片类药物会降低巨噬细胞祖细胞和淋巴细胞的增殖能力。此外,免疫细胞的分化功能也会受到阿片类药物的显著影响。这些效应是由阿片类药物对靶细胞的直接作用或间接的中枢介导途径介导的。分子生物学和生化特性表明,免疫细胞差异表达经典阿片受体。有趣的是,这些研究还揭示了免疫细胞中存在一类新型阿片受体。我们认为,这个低亲和力吗啡结合位点介导了吗啡的抗增殖作用。